1. Home
  2. CRON vs PDT Comparison

CRON vs PDT Comparison

Compare CRON & PDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRON
  • PDT
  • Stock Information
  • Founded
  • CRON 2012
  • PDT 1989
  • Country
  • CRON Canada
  • PDT United States
  • Employees
  • CRON N/A
  • PDT N/A
  • Industry
  • CRON Medicinal Chemicals and Botanical Products
  • PDT Finance Companies
  • Sector
  • CRON Health Care
  • PDT Finance
  • Exchange
  • CRON Nasdaq
  • PDT Nasdaq
  • Market Cap
  • CRON 795.2M
  • PDT 648.3M
  • IPO Year
  • CRON N/A
  • PDT N/A
  • Fundamental
  • Price
  • CRON $1.94
  • PDT $12.22
  • Analyst Decision
  • CRON Hold
  • PDT
  • Analyst Count
  • CRON 2
  • PDT 0
  • Target Price
  • CRON $3.00
  • PDT N/A
  • AVG Volume (30 Days)
  • CRON 1.0M
  • PDT 145.6K
  • Earning Date
  • CRON 11-12-2024
  • PDT 01-01-0001
  • Dividend Yield
  • CRON N/A
  • PDT 8.88%
  • EPS Growth
  • CRON N/A
  • PDT N/A
  • EPS
  • CRON N/A
  • PDT N/A
  • Revenue
  • CRON $111,229,000.00
  • PDT N/A
  • Revenue This Year
  • CRON $35.84
  • PDT N/A
  • Revenue Next Year
  • CRON $15.66
  • PDT N/A
  • P/E Ratio
  • CRON N/A
  • PDT N/A
  • Revenue Growth
  • CRON 30.31
  • PDT N/A
  • 52 Week Low
  • CRON $1.86
  • PDT $8.77
  • 52 Week High
  • CRON $3.14
  • PDT $13.05
  • Technical
  • Relative Strength Index (RSI)
  • CRON 43.81
  • PDT 28.74
  • Support Level
  • CRON $1.90
  • PDT $12.26
  • Resistance Level
  • CRON $2.00
  • PDT $13.08
  • Average True Range (ATR)
  • CRON 0.06
  • PDT 0.18
  • MACD
  • CRON -0.00
  • PDT -0.08
  • Stochastic Oscillator
  • CRON 34.78
  • PDT 4.93

About CRON Cronos Group Inc. Common Share

Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

About PDT John Hancock Premium Dividend Fund

John Hancock Premium Div Fund II is a United States-based closed-end management investment company. It seeks to provide a high current income consistent with modest growth of capital. The fund will pursue its objective by investing in a diversified portfolio comprised of dividend-paying preferred securities and common equity securities. The portfolio composition of the fund consists of preferred securities, common stocks, corporate bonds, and short-term investments.

Share on Social Networks: